tubocurarine has been researched along with Leukemia, Myelomonocytic, Acute in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Karelin, AA | 1 |
1 other study(ies) available for tubocurarine and Leukemia, Myelomonocytic, Acute
| Article | Year |
|---|---|
Tubocurarin induces the wide spectrum of cytolytic effects in tumor cells.
Topics: Animals; Apoptosis; Cell Death; DNA Damage; DNA, Neoplasm; Fibrosarcoma; Humans; Leukemia, Erythroblastic, Acute; Leukemia, Myelomonocytic, Acute; Macrophages, Peritoneal; Mice; Mice, Inbred BALB C; Tubocurarine; Tumor Cells, Cultured | 1994 |